Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Work In Process of $9.0 million in Q1 2026, up 22.7% quarter-over-quarter from $7.3 million in Q4 2025, and down 9.44% on a YoY basis from $9.9 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Work In Process history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Work In Process fell 9.44% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 9.44% YoY), while the FY2025 annual figure was $7.3 million, down 27.18% from the prior year.
- Work In Process was $9.0 million for Q1 2026 at Maravai Lifesciences Holdings, up from $7.3 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $30.6 million in Q3 2022 to a low of $7.3 million in Q4 2025.
- Historically, Work In Process has averaged $15.0 million across 5 years, with a median of $12.2 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Work In Process jumped 30.73% in 2022, then plunged 60.06% in 2023.
- A 5-year view of Work In Process shows it stood at $22.0 million in 2022, then tumbled by 42.23% to $12.7 million in 2023, then fell by 20.74% to $10.0 million in 2024, then retreated by 27.18% to $7.3 million in 2025, then rose by 22.7% to $9.0 million in 2026.
- The last three Work In Process figures came in at $9.0 million (Q1 2026), $7.3 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Maravai Lifesciences Holdings | 737.25 Mn | 728.85 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.98 Mn |
| Dec 31, 2025 | 7.32 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 10.52 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Dec 31, 2024 | 10.05 Mn |
| Sep 30, 2024 | 10.75 Mn |
| Jun 30, 2024 | 11.02 Mn |
| Mar 31, 2024 | 12.53 Mn |
| Dec 31, 2023 | 12.68 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 14.50 Mn |
| Mar 31, 2023 | 22.17 Mn |
| Dec 31, 2022 | 21.95 Mn |
| Sep 30, 2022 | 30.57 Mn |
| Jun 30, 2022 | 30.07 Mn |
| Mar 31, 2022 | 20.55 Mn |
| Dec 31, 2021 | 21.38 Mn |
| Sep 30, 2021 | 25.43 Mn |
| Jun 30, 2021 | 23.00 Mn |